BALA MOHAN (SVP, Chief Development Officer) sold 18.0% of their position (1.91K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/27/2023ACC: 0001104659-23-112168
Officer· SVP, Chief Development Officer
Since Sep 2023
-1.91K
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
142.2%
10/25/2023
4.39K→10.64K
Common Stock
Direct
Shares
−1.91K
Price / share
$1.13
Trade value
$2.16K
% of position
18.0%
10/26/2023
10.64K→8.73K
Total
Net shares
+4.34K
Net value
-$2.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2023 | M · Option Exercise | +6.25K | — | — | 142.2% | 4.39K | 10.64K |
| Common Stock Direct | 10/26/2023 | S · Sale | −1.91K | $1.13 | $2.16K | 18.0% | 10.64K | 8.73K |
| Total | +4.34K | -$2.16K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
12.50K
Exercisable
—
10/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 10/25/2023 | M · Option Exercise | −6.25K | — | 12.50K |